Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29251 - 29275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	SERPINB7	8710	downregulated	Dasatinib results in decreased expression of SERPINB7 mRNA	18q21.33	A21899
Dasatinib	Approved Investigational	SGO1	151648	downregulated	Dasatinib results in decreased expression of SGO1 mRNA	3p24.3	A21899
Dasatinib	Approved Investigational	SGO2	151246	downregulated	Dasatinib results in decreased expression of SGO2 mRNA	2q33.1	A21899
Dasatinib	Approved Investigational	SHCBP1	79801	downregulated	Dasatinib results in decreased expression of SHCBP1 mRNA	16q11.2	A21899
Dasatinib	Approved Investigational	SKA1	220134	downregulated	Dasatinib results in decreased expression of SKA1 mRNA	18q21.1	A21899
Dasatinib	Approved Investigational	SKA3	221150	downregulated	Dasatinib results in decreased expression of SKA3 mRNA	13q12.11	A21899
Dasatinib	Approved Investigational	SLC16A6	9120	downregulated	Dasatinib results in decreased expression of SLC16A6 mRNA	17q24.2	A21899
Dasatinib	Approved Investigational	SLC1A4	6509	upregulated	Dasatinib results in increased expression of SLC1A4 mRNA	2p14	A21899
Dasatinib	Approved Investigational	SLC20A1	6574	downregulated	Dasatinib results in decreased expression of SLC20A1 mRNA	2q14.1	A21899
Dasatinib	Approved Investigational	SLC40A1	30061	upregulated	Dasatinib results in increased expression of SLC40A1 mRNA	2q32.2	A21899
Dasatinib	Approved Investigational	SLC6A6	6533	upregulated	Dasatinib results in increased expression of SLC6A6 mRNA	3p25.1	A21899
Dasatinib	Approved Investigational	SLFN11	91607	downregulated	Dasatinib results in decreased expression of SLFN11 mRNA	17q12	A21899
Dasatinib	Approved Investigational	SMC2	10592	downregulated	Dasatinib results in decreased expression of SMC2 mRNA	9q31.1	A21899
Dasatinib	Approved Investigational	SMC4	10051	downregulated	Dasatinib results in decreased expression of SMC4 mRNA	3q25.33	A21899
Dasatinib	Approved Investigational	SNORD14E	85391	downregulated	Dasatinib results in decreased expression of SNORD14E mRNA	11q23.3-q25	A21899
Dasatinib	Approved Investigational	SNORD30	9299	downregulated	Dasatinib results in decreased expression of SNORD30 mRNA	11q12.3	A21899
Dasatinib	Approved Investigational	SNORD50B	692088	downregulated	Dasatinib results in decreased expression of SNORD50B mRNA	6q14.3	A21899
Dasatinib	Approved Investigational	SOX4	6659	upregulated	Dasatinib results in increased expression of SOX4 mRNA	6p22.3	A21899
Dasatinib	Approved Investigational	SPRY2	10253	downregulated	Dasatinib results in decreased expression of SPRY2 mRNA	13q31.1	A21899
Dasatinib	Approved Investigational	STC1	6781	downregulated	Dasatinib results in decreased expression of STC1 mRNA	8p21.2	A21899
Dasatinib	Approved Investigational	STEAP1	26872	downregulated	Dasatinib results in decreased expression of STEAP1 mRNA	7q21.13	A21899
Dasatinib	Approved Investigational	STEAP1B	256227	downregulated	Dasatinib results in decreased expression of STEAP1B mRNA	7p15.3	A21899
Dasatinib	Approved Investigational	STIL	6491	downregulated	Dasatinib results in decreased expression of STIL mRNA	1p33	A21899
Dasatinib	Approved Investigational	STK38L	23012	upregulated	Dasatinib results in increased expression of STK38L mRNA	12p11.23	A21899
Dasatinib	Approved Investigational	STMN1	3925	downregulated	Dasatinib results in decreased expression of STMN1 mRNA	1p36.11	A21899

Displaying entries 29251 - 29275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability